EfficientNetB7-Based Deep Learning Framework for Enhanced Classification of Lung and Colon Cancer Histopathological Images.
1/5 보강
Early diagnosis of lung cancer plays a pivotal role in ensuring improved treatment and survival of patients.
APA
Aditya PH, Mahesh TR, et al. (2026). EfficientNetB7-Based Deep Learning Framework for Enhanced Classification of Lung and Colon Cancer Histopathological Images.. Journal of visualized experiments : JoVE(228). https://doi.org/10.3791/68812
MLA
Aditya PH, et al.. "EfficientNetB7-Based Deep Learning Framework for Enhanced Classification of Lung and Colon Cancer Histopathological Images.." Journal of visualized experiments : JoVE, no. 228, 2026.
PMID
41729802 ↗
DOI
10.3791/68812
Abstract 한글 요약
Early diagnosis of lung cancer plays a pivotal role in ensuring improved treatment and survival of patients. This remains a major focus in clinical research. Artificial intelligence (AI) has transformed pathology by significantly improving diagnostic accuracy and efficiency. This study presents a robust deep learning model in the shape of the pretrained EfficientNetB7 model to classify colon and lung tissue histopathological images with an extremely high accuracy of 96%. The model's performance was optimized using advanced preprocessing methods, fine-tuning, and domain-specific data augmentation techniques. These strategies help reduce problems such as class imbalance and subtle histological variations. To address the issue of overfitting, multiple data augmentation techniques were combined, and an early stopping criterion was incorporated. This approach enabled efficient and cost-effective training. Robust validation of the model demonstrates high utility for clinical applications and enables pathologists to deliver timely and accurate diagnoses. Integrating advanced deep learning models into medical imaging workflows holds great promise for early and accurate cancer diagnosis, ultimately improving patient outcomes.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.
- Early local immune activation following intra-operative radiotherapy in human breast tissue.